About
As Vice President in Oncology R&D at AstraZeneca, I lead the early Oncology Projects…
Activity
-
Congratulations to Maria Letizia Giardino Torchia, Gordon Moody and the Cell Therapy team at AstraZeneca. By developing the DIAL framework, you are…
Congratulations to Maria Letizia Giardino Torchia, Gordon Moody and the Cell Therapy team at AstraZeneca. By developing the DIAL framework, you are…
Shared by Daniel Freeman
-
Identifying the best possible disease targets along with a substantial toolbox of modality capabilities are critical parts of developing new…
Identifying the best possible disease targets along with a substantial toolbox of modality capabilities are critical parts of developing new…
Shared by Daniel Freeman
Experience
Education
Organizations
-
AACR, ASCO, SITC
-
More activity by Daniel
-
The better we get at selecting patients most likely to respond to treatment, the more meaningful impact we will make with our…
The better we get at selecting patients most likely to respond to treatment, the more meaningful impact we will make with our…
Shared by Daniel Freeman
-
One of the most rewarding parts of my career has been mentoring colleagues to help advance their careers in industry and achieve their full…
One of the most rewarding parts of my career has been mentoring colleagues to help advance their careers in industry and achieve their full…
Shared by Daniel Freeman
-
In 2020, we launched our immuno-oncology (IO) framework that goes beyond T cells for how the immune system engages with cancer cells. Just three…
In 2020, we launched our immuno-oncology (IO) framework that goes beyond T cells for how the immune system engages with cancer cells. Just three…
Shared by Daniel Freeman
-
Thrilled to be onsite at #ESMO23, where our team is showcasing the strides we’ve made with our diverse portfolio including, the #immunotherapy…
Thrilled to be onsite at #ESMO23, where our team is showcasing the strides we’ve made with our diverse portfolio including, the #immunotherapy…
Shared by Daniel Freeman
-
As we continue to explore collaboration opportunities in China, an important focus is on building and fostering strong networks. It was therefore…
As we continue to explore collaboration opportunities in China, an important focus is on building and fostering strong networks. It was therefore…
Liked by Daniel Freeman
-
A great article with Mark Cobbold on our immuno-oncology (IO) research framework, and how it has helped guide us since 2020 to build a diverse…
A great article with Mark Cobbold on our immuno-oncology (IO) research framework, and how it has helped guide us since 2020 to build a diverse…
Shared by Daniel Freeman
-
As we continue to explore collaboration opportunities in China, an important focus is on building and fostering strong networks. It was therefore…
As we continue to explore collaboration opportunities in China, an important focus is on building and fostering strong networks. It was therefore…
Shared by Daniel Freeman
-
A great visit to our Munich site for a science deep dive with the Computational Pathology team – With all of the Antibody Drug Conjugates, T -Cell…
A great visit to our Munich site for a science deep dive with the Computational Pathology team – With all of the Antibody Drug Conjugates, T -Cell…
Shared by Daniel Freeman
-
An exciting opportunity to align your career with AZ and work along side Daniel Freeman Martin Pass Andrew Mortlock to help drive forward the next…
An exciting opportunity to align your career with AZ and work along side Daniel Freeman Martin Pass Andrew Mortlock to help drive forward the next…
Liked by Daniel Freeman
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Daniel Freeman in United States
-
Daniel Freeman
Director of Digital Development at R&R Partners
-
Daniel Freeman
-
Daniel Freeman
-
Daniel Freeman
727 others named Daniel Freeman in United States are on LinkedIn
See others named Daniel Freeman